Definitive Cefazolin Therapy for Stabilized Adults with Community-Onset <i>Escherichia coli</i>, <i>Klebsiella</i> Species, and <i>Proteus mirabilis</i> Bacteremia: MIC Matters

Definitive Cefazolin Therapy for Stabilized Adults with Community-Onset <i>Escherichia coli</i>, <i>Klebsiella</i> Species, and <i>Proteus mirabilis</i> Bacteremia: MIC Matters

Background: Cefazolin is in vitro active against wild isolates of <i>Escherichia coli</i>, <i>Klebsiella</i> species, and <i>Proteus mirabilis</i> (EKP), but clinical evidence supporting the contemporary susceptibility breakpoint issued by the Clinical and Laborat...

Full description

Bibliographic Details
Main Authors: Chih-Chia Hsieh, Po-Lin Chen, Chung-Hsun Lee, Chao-Yung Yang, Ching-Chi Lee, Wen-Chien Ko
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Journal of Clinical Medicine
Subjects:
cefazolin
definitive therapy
bacteremia
<i>escherichia coli</i>
<i>klebsiella pneumoniae</i>
<i>proteus mirabilis</i>
Online Access:https://www.mdpi.com/2077-0383/9/1/157

Internet

https://www.mdpi.com/2077-0383/9/1/157

Similar Items